Platelet additive solution having a beta-galactosidase inhibitor

作者: Robert Sackstein , Karin Hoffmeister , Qiyong Peter Liu

DOI:

关键词:

摘要: The present invention relates to a platelet additive solution (PAS) having an amount of one or more β-galactosidase inhibitors with without sialidase inhibitors, and optionally glycan-modifying agents; PAS components that include salt, citrate source, carbon any combination thereof.

参考文章(230)
Nicholas Stamatos, Alan S. Cross, Daniel G. Wright, Peter Gomatos, Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents ,(1995)
Eugenio Monti, Erik Bonten;, Alessandra D'Azzo, Roberto Bresciani, Bruno Venerando, Giuseppe Borsani, Roland Schauer, Guido Tettamanti, Sialidases in Vertebrates : A Family Of Enzymes Tailored For Several Cell Functions* Advances in Carbohydrate Chemistry and Biochemistry. ,vol. 64, pp. 403- 479 ,(2010) , 10.1016/S0065-2318(10)64007-3
Gerard R. DelGiacco, Randy Garcez, Isaac Rothman, Richard Salinaro, Thomas Gsell, Method for processing a biological fluid ,(1999)
David J. Kuter, David Beeler, Robert D. Rosenberg, Method of using megapoietin for prolonging the survival & viability of platlets ,(1994)
R. C. Sheppard, E. Atherton, Solid phase peptide synthesis : a practical approach IRL Press. ,(1989)
Simeon Goldblum, Alan Cross, Nicholas Stamatos, Method of treating inflammation with inhibitors of sialyl transferases ,(2005)